Elise A. Olsen, MD, FAAD
Duke University
BIOGRAPHY
Dr. Olsen is Professor of Dermatology and Medicine at Duke University and Founder and Director of the Duke University Hair Disorders Research and Treatment Center. She is one of the founders and past President of the American Hair Research Society (AHRS). She is the editor of the first and second editions of the textbook, "Hair Disorders: Diagnosis and Treatment. Dr. Olsen helped to define and name female pattern hair loss, helped to create the current classification of cicatricial alopecia, led the first multicenter trial of central centrifugal cicatricial alopecia (CCCA) and the development of a photographic scale for CCCA, led a multicenter US study and international guidelines for clinical trials of FFA, and helped to create the SALT score used to determine the efficacy of treatments for alopecia areata. She has also developed the ALODEX score for assessment of various types of hair disorders. She has developed guidelines for the assessment of chemotherapy related hair loss both for the Multinational Association of Supportive Care in Cancer (MASCC) and the NCI CTCAE V4.0 used for tracking side effects of medications considered for FDA approval. She serves as a consultant on the Undiagnosed Disease Network for children with hair loss. She received the second David Whiting Research and Leadership award of the AHRS. She is on the Board of Directors of the Scarring Alopecia Foundation (SAF) and the Medical Advisory Board of the National Alopecia Areata Foundation (NAAF). Dr. Olsen is a past Vice-President, Director, and Honorary member of the AAD, founder and first President of the NC Dermatology Association, President of the 10 institution Southeastern Consortium for Dermatology, and recipient of the Dermatology Foundation Honorary Lifetime Career Educator Award.
SESSIONS
DISCLOSURES
Absci – Advisory Board(Honoraria); Aranda Pharm Ltd – Consultant (1099 relationship)(Honoraria); Canfield Scientific, Inc. – Consultant(Honoraria); Cosmos S.I. – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); Taisho Pharmaceuticals Co., Ltd. – Consultant (1099 relationship)(Honoraria); United States Cutaneous Lymphoma Consortium – Other(Grants/Research Funding); UpToDate, Inc – Other(Honoraria); VeraDermics Inc. – Consultant (1099 relationship)(Honoraria);